| PLCB1 |
PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- |
APBA2 |
APBA2, MINT2, X11L: Amyloid beta A4 precursor protein-binding family A member 2 |
0.263 |
Evidence |
|
| EEF1G |
EEF1G, EF1G, PRO1608: Elongation factor 1-gamma |
YARS |
YARS: Tyrosyl-tRNA synthetase, cytoplasmic |
0.263 |
Evidence |
|
| MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
TRIP13 |
TRIP13: Thyroid receptor-interacting protein 13 |
0.263 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
NEK9 |
NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 |
0.263 |
Evidence |
|
| RELA |
RELA, NFKB3: Transcription factor p65 |
ILK |
ILK, ILK1, ILK2: Integrin-linked protein kinase |
0.263 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
0.263 |
Evidence |
|
| PCBP2 |
PCBP2: Poly(rC)-binding protein 2 |
RBM15 |
RBM15, OTT: Putative RNA-binding protein 15 |
0.263 |
Evidence |
|
| ITGB7 |
ITGB7: Integrin beta-7 precursor |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
0.263 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
ADAM17 |
ADAM17, CSVP, TACE: ADAM 17 precursor |
0.263 |
Evidence |
|
| MYCBP2 |
MYCBP2, KIAA0916, PAM: Probable E3 ubiquitin-protein ligase MYCBP2 |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
0.263 |
Evidence |
|
| ADAM17 |
ADAM17, CSVP, TACE: ADAM 17 precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.263 |
Evidence |
|
| SNRPB2 |
SNRPB2: U2 small nuclear ribonucleoprotein B'' |
PCBP1 |
PCBP1: Poly(rC)-binding protein 1 |
0.263 |
Evidence |
|
| STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
0.263 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
0.263 |
Evidence |
|
| AKAP8 |
AKAP8, AKAP95: A-kinase anchor protein 8 |
DPF2 |
DPF2, REQ, UBID4: Zinc finger protein ubi-d4 |
0.263 |
Evidence |
|
| PSMD4 |
PSMD4, MCB1: 26S proteasome non-ATPase regulatory subunit 4 |
EHD1 |
EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 |
0.263 |
Evidence |
|
| SSB |
SSB: Lupus La protein |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
0.263 |
Evidence |
|
| G3BP |
G3BP1, G3BP: Ras GTPase-activating protein-binding protein 1 |
SAFB |
SAFB, HAP, HET, SAFB1: Scaffold attachment factor B |
0.263 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
NEK9 |
NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 |
0.263 |
Evidence |
|
| PSMD11 |
PSMD11: 26S proteasome non-ATPase regulatory subunit 11 |
CLTC |
CLTC, CLH17, CLTCL2, KIAA0034: Clathrin heavy chain 1 |
0.263 |
Evidence |
|
| SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
NOTCH2 |
NOTCH2: Neurogenic locus notch homolog protein 2 precursor |
0.263 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
SNRP70 |
SNRP70, RNPU1Z, RPU1, U1AP1: U1 small nuclear ribonucleoprotein 70 kDa |
0.263 |
Evidence |
|
| FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
SAFB |
SAFB, HAP, HET, SAFB1: Scaffold attachment factor B |
0.263 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
SNX17 |
SNX17, KIAA0064: Sorting nexin-17 |
0.263 |
Evidence |
|
| SOS1 |
SOS1: Son of sevenless homolog 1 |
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
0.263 |
Evidence |
|
- 
- 
-